课题基金 / 基金详情

Cross Presentation and tumour immunology

Cross Presentation and tumour immunology
交叉展示和肿瘤免疫学
批准号:
nhmrc : 1029589
负责人:
Prof Anna Nowak
金额:
$29.68万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2012
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2012-01-01 至 2015-12-31

项目摘要

项目成果

Prof Anna Nowak的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancers have thousands of mutations, so they should look a bit like a viral infection. If so, why doesn’t the immune system just destroy them outright, like they would a virus? We think the mutated proteins cause a ‘brake’ to be put on the anti-cancer immune response, and also that cancers subvert the anti-cancer attack by remaining hidden in the target zone. Unblocking these “brakes” might lead to new treatments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving treatment outcomes for malignant mesothelioma patients using biomarkers.
  • 批准号:
    nhmrc : 1063067
  • 项目类别:
    Project Grants
  • 资助金额:
    $53.03万
  • 财政年份:
    2014
  • 负责人:
    Prof Anna Nowak
  • 依托单位:
Can biomarkers improve outcomes for the asbestos-induced cancer malignant mesothelioma?
  • 批准号:
    nhmrc : GNT1063067
  • 项目类别:
    Project Grants
  • 资助金额:
    $51.28万
  • 财政年份:
    2014
  • 负责人:
    Prof Anna Nowak
  • 依托单位:
National Centre for Asbestos Related Diseases
  • 批准号:
    nhmrc : 1001020
  • 项目类别:
    Centres of Research Excellence
  • 资助金额:
    $341.4万
  • 财政年份:
    2010
  • 负责人:
    Prof Anna Nowak
  • 依托单位:
海外基金